These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 36484017)

  • 1. The European Prevention of Alzheimer's Dementia Programme: An Innovative Medicines Initiative-funded partnership to facilitate secondary prevention of Alzheimer's disease dementia.
    Saunders S; Gregory S; Clement MHS; Birck C; van der Geyten S; Ritchie CW
    Front Neurol; 2022; 13():1051543. PubMed ID: 36484017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. European Prevention of Alzheimer's Dementia Longitudinal Cohort Study (EPAD LCS): study protocol.
    Solomon A; Kivipelto M; Molinuevo JL; Tom B; Ritchie CW;
    BMJ Open; 2019 Feb; 8(12):e021017. PubMed ID: 30782589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The European Prevention of Alzheimer's Dementia (EPAD) Longitudinal Cohort Study: Baseline Data Release V500.0.
    Ritchie CW; Muniz-Terrera G; Kivipelto M; Solomon A; Tom B; Molinuevo JL
    J Prev Alzheimers Dis; 2020; 7(1):8-13. PubMed ID: 32010920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of interventions for the secondary prevention of Alzheimer's dementia: the European Prevention of Alzheimer's Dementia (EPAD) project.
    Ritchie CW; Molinuevo JL; Truyen L; Satlin A; Van der Geyten S; Lovestone S;
    Lancet Psychiatry; 2016 Feb; 3(2):179-86. PubMed ID: 26683239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Participating in innovative medicines initiative funded neurodegenerative disorder projects-An impact analysis conducted as part of the NEURONET project.
    Hawksworth C; Salih F; Cresswell K; Steukers L; Diaz C; Killin L; Pradier L; Bradshaw A; Dawoud D
    Front Neurol; 2023; 14():1140722. PubMed ID: 37006486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prescreening for European Prevention of Alzheimer Dementia (EPAD) trial-ready cohort: impact of AD risk factors and recruitment settings.
    Vermunt L; Muniz-Terrera G; Ter Meulen L; Veal C; Blennow K; Campbell A; Carrié I; Delrieu J; Fauria K; Huesa Rodríguez G; Ingala S; Jenkins N; Molinuevo JL; Ousset PJ; Porteous D; Prins ND; Solomon A; Tom BD; Zetterberg H; Zwan M; Ritchie CW; Scheltens P; Luscan G; Brookes AJ; Visser PJ;
    Alzheimers Res Ther; 2020 Jan; 12(1):8. PubMed ID: 31907067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re-Engineering Alzheimer Clinical Trials: Global Alzheimer's Platform Network.
    Cummings J; Aisen P; Barton R; Bork J; Doody R; Dwyer J; Egan JC; Feldman H; Lappin D; Truyen L; Salloway S; Sperling R; Vradenburg G
    J Prev Alzheimers Dis; 2016 Jun; 3(2):114-120. PubMed ID: 28459045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Innovative Medicines Initiative neurodegeneration portfolio: From individual projects to collaborative networks.
    O'Rourke D; Coll-Padrós N; Bradshaw A; Killin L; Pradier L; Georges J; Dawoud DM; Steukers L; Diaz C
    Front Neurol; 2022; 13():994301. PubMed ID: 36408524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recommended cognitive outcomes in preclinical Alzheimer's disease: Consensus statement from the European Prevention of Alzheimer's Dementia project.
    Ritchie K; Ropacki M; Albala B; Harrison J; Kaye J; Kramer J; Randolph C; Ritchie CW
    Alzheimers Dement; 2017 Feb; 13(2):186-195. PubMed ID: 27702619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. European Prevention of Alzheimer's Dementia Registry: Recruitment and prescreening approach for a longitudinal cohort and prevention trials.
    Vermunt L; Veal CD; Ter Meulen L; Chrysostomou C; van der Flier W; Frisoni GB; Guessous I; Kivipelto M; Marizzoni M; Martinez-Lage P; Molinuevo JL; Porteous D; Ritchie K; Scheltens P; Ousset PJ; Ritchie CW; Luscan G; Brookes AJ; Visser PJ
    Alzheimers Dement; 2018 Jun; 14(6):837-842. PubMed ID: 29604264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Models and methods: a perspective of the impact of six IMI translational data-centric initiatives for Alzheimer's disease and other neuropsychiatric disorders.
    North H; Hofmann-Apitius M; Kas MJH; Marston H; Haas M
    Front Neurol; 2023; 14():1174079. PubMed ID: 37521302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. European Projects for Patients with Dementia and Their Caregivers.
    Tsolaki M; Makri M; Tsatali M; Teichmann Β
    Adv Exp Med Biol; 2023; 1425():609-618. PubMed ID: 37581834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions between apolipoprotein E, sex, and amyloid-beta on cerebrospinal fluid p-tau levels in the European prevention of Alzheimer's dementia longitudinal cohort study (EPAD LCS).
    Saunders TS; Jenkins N; Blennow K; Ritchie C; Muniz-Terrera G
    EBioMedicine; 2022 Sep; 83():104241. PubMed ID: 36041266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Innovative Medicines Initiative -10 Years of Public-Private Collaboration.
    Laverty H; Meulien P
    Front Med (Lausanne); 2019; 6():275. PubMed ID: 31850354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Goal-oriented cognitive rehabilitation for early-stage Alzheimer's and related dementias: the GREAT RCT.
    Clare L; Kudlicka A; Oyebode JR; Jones RW; Bayer A; Leroi I; Kopelman M; James IA; Culverwell A; Pool J; Brand A; Henderson C; Hoare Z; Knapp M; Morgan-Trimmer S; Burns A; Corbett A; Whitaker R; Woods B
    Health Technol Assess; 2019 Mar; 23(10):1-242. PubMed ID: 30879470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involving research participants in a pan-European research initiative: the EPAD participant panel experience.
    Gregory S; Bunnik EM; Callado AB; Carrie I; De Boer C; Duffus J; Fauria K; Forster S; Gove D; Knezevic I; Laquidain A; Pennetier D; Saunders S; Sparks S; Rice J; Ritchie CW; Milne R
    Res Involv Engagem; 2020; 6():62. PubMed ID: 33088590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive Functions as Predictors of Alzheimer's Disease Biomarker Status in the European Prevention of Alzheimer's Dementia Cohort.
    Terrera GM; Harrison JE; Ritchie CW; Ritchie K
    J Alzheimers Dis; 2020; 74(4):1203-1210. PubMed ID: 32144988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a novel dementia risk prediction model in the general population: A large, longitudinal, population-based machine-learning study.
    You J; Zhang YR; Wang HF; Yang M; Feng JF; Yu JT; Cheng W
    EClinicalMedicine; 2022 Nov; 53():101665. PubMed ID: 36187723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Open-Access European Prevention of Alzheimer's Dementia (EPAD) MRI dataset and processing workflow.
    Lorenzini L; Ingala S; Wink AM; Kuijer JPA; Wottschel V; Dijsselhof M; Sudre CH; Haller S; Molinuevo JL; Gispert JD; Cash DM; Thomas DL; Vos SB; Prados F; Petr J; Wolz R; Palombit A; Schwarz AJ; Chételat G; Payoux P; Di Perri C; Wardlaw JM; Frisoni GB; Foley C; Fox NC; Ritchie C; Pernet C; Waldman A; Barkhof F; Mutsaerts HJMM;
    Neuroimage Clin; 2022; 35():103106. PubMed ID: 35839659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Research participants as collaborators: Background, experience and policies from the PREVENT Dementia and EPAD programmes.
    Gregory S; Wells K; Forysth K; Latto C; Szyra H; Saunders S; Ritchie CW; Milne R
    Dementia (London); 2018 Nov; 17(8):1045-1054. PubMed ID: 30373458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.